Matthieu Mahevas

Summary

Country: France

Publications

  1. ncbi Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine
    Matthieu Mahevas
    1Department of Internal Medicine, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Creteil, France
    Haematologica 92:e78-9. 2007
  2. ncbi [Haematopoietic stem cell transplantation in the treatment of autoimmune diseases]
    M Mahevas
    Service de Medecine Interne, Hopital Nord, CHU d Amiens, Place Victor Pauchet, 80054 Amiens Cedex 1, France
    Rev Med Interne 29:115-21. 2008
  3. doi Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients
    Matthieu Mahevas
    Department of Internal Medicine, Amiens Nord Hospital, Amiens, France
    Medicine (Baltimore) 88:98-106. 2009
  4. doi Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients
    Matthieu Mahevas
    Department of Internal Medicine, Henri Mondor Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    Medicine (Baltimore) 90:269-78. 2011
  5. ncbi The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
    Matthieu Mahevas
    Service de Medecine Interne, centre de référence des cytopénies auto immunes de l adulte, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Université Paris Est Créteil, Creteil, France Etablissement Français du Sang Ile de France, INSERM U955, Creteil, Hopital Henri Mondor, Paris, France
    Br J Haematol 165:865-9. 2014
  6. doi Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
    Matthieu Mahevas
    Department of Internal Medicine, centre de référence des cytopénies auto immunes de l adulte, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Université Paris Est Créteil, Creteil, France Etablissement Français du Sang Ile de France, INSERM U955, Creteil, Hopital Henri Mondor, Paris, France
    Am J Hematol 88:858-61. 2013
  7. ncbi Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients
    Mathilde Roumier
    APHP, Henri Mondor Hospital, Department of Internal Medicine, French National Referral Center For Adults Immune Cytopenias, Creteil, France
    Am J Hematol 89:E150-5. 2014
  8. doi A case-control study to assess the risk of immune thrombocytopenia associated with vaccines
    Lamiae Grimaldi-Bensouda
    LA SER, 10 Place de Catalogne, Paris, France
    Blood 120:4938-44. 2012
  9. pmc B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
    Matthieu Mahevas
    Faculte de Medecine, Site Necker Enfants Malades, INSERM U783 Développement du système immunitaire, Universite Paris Descartes, Paris, France
    J Clin Invest 123:432-42. 2013
  10. ncbi Scalp necrosis in giant cell arteritis
    Matthieu Mahevas
    Department of Internal Medicine, Henri Mondor University Hospital, Creteil, France
    J Rheumatol 34:442-3. 2007

Collaborators

Detail Information

Publications12

  1. ncbi Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine
    Matthieu Mahevas
    1Department of Internal Medicine, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Creteil, France
    Haematologica 92:e78-9. 2007
  2. ncbi [Haematopoietic stem cell transplantation in the treatment of autoimmune diseases]
    M Mahevas
    Service de Medecine Interne, Hopital Nord, CHU d Amiens, Place Victor Pauchet, 80054 Amiens Cedex 1, France
    Rev Med Interne 29:115-21. 2008
    ..These new therapeutic have been used in systemic sclerosis (scleroderma), multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis and systemic lupus erythematosus...
  3. doi Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients
    Matthieu Mahevas
    Department of Internal Medicine, Amiens Nord Hospital, Amiens, France
    Medicine (Baltimore) 88:98-106. 2009
    ....
  4. doi Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients
    Matthieu Mahevas
    Department of Internal Medicine, Henri Mondor Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    Medicine (Baltimore) 90:269-78. 2011
    ....
  5. ncbi The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
    Matthieu Mahevas
    Service de Medecine Interne, centre de référence des cytopénies auto immunes de l adulte, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Université Paris Est Créteil, Creteil, France Etablissement Français du Sang Ile de France, INSERM U955, Creteil, Hopital Henri Mondor, Paris, France
    Br J Haematol 165:865-9. 2014
    ..We could not identify a predictive factor of sustained response. In conclusion, a substantial proportion of ITP patients receiving Tpo-RAs can maintain a durable response after treatment discontinuation. ..
  6. doi Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
    Matthieu Mahevas
    Department of Internal Medicine, centre de référence des cytopénies auto immunes de l adulte, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Université Paris Est Créteil, Creteil, France Etablissement Français du Sang Ile de France, INSERM U955, Creteil, Hopital Henri Mondor, Paris, France
    Am J Hematol 88:858-61. 2013
    ..Tolerance was good and comparable between the two groups. The RA regimen is an effective and safe alternative to the standard regimen to treat adults with ITP...
  7. ncbi Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients
    Mathilde Roumier
    APHP, Henri Mondor Hospital, Department of Internal Medicine, French National Referral Center For Adults Immune Cytopenias, Creteil, France
    Am J Hematol 89:E150-5. 2014
    ..18%). Am. J. Hematol. 89:E150-E155, 2014. © 2014 Wiley Periodicals, Inc. ..
  8. doi A case-control study to assess the risk of immune thrombocytopenia associated with vaccines
    Lamiae Grimaldi-Bensouda
    LA SER, 10 Place de Catalogne, Paris, France
    Blood 120:4938-44. 2012
    ..5) and was not statistically significant. The results of the present study show that in an adult population, the exposure to common vaccines is on average not associated with an observable risk of developing ITP...
  9. pmc B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
    Matthieu Mahevas
    Faculte de Medecine, Site Necker Enfants Malades, INSERM U783 Développement du système immunitaire, Universite Paris Descartes, Paris, France
    J Clin Invest 123:432-42. 2013
    ..Surprisingly, long-lived PC were not detected in untreated ITP spleens. These results suggest that the milieu generated by B cell depletion promotes the differentiation and settlement of long-lived PC in the spleen...
  10. ncbi Scalp necrosis in giant cell arteritis
    Matthieu Mahevas
    Department of Internal Medicine, Henri Mondor University Hospital, Creteil, France
    J Rheumatol 34:442-3. 2007
  11. ncbi Thrombocytopenia in sarcoidosis
    Matthieu Mahevas
    Department of Internal Medicine, CHU Nord, Amiens Cedex 1, France
    Sarcoidosis Vasc Diffuse Lung Dis 23:229-35. 2006
    ..Haematological manifestations in sarcoidosis are uncommon. The prevalence of thrombocytopenia in sarcoidosis is not well assessed...
  12. doi Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program
    Mehdi Khellaf
    Department of Internal Medicine, Centre Hospitalier Universitaire Henri Mondor, Assistance Publique Hopitaux de Paris, Université Paris Est Créteil, Creteil, France
    Blood 118:4338-45. 2011
    ..Our results confirmed that romiplostim use in clinical practice is effective and safe for severe chronic ITP. This trial was registered at www.clinicaltrials.gov as #NCT01013181...